Critical Review: Disaboom (OTCMKTS:MEDH) and TransMedics Group (NASDAQ:TMDX)

Disaboom (OTCMKTS:MEDH) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, dividends, analyst recommendations and risk.

Valuation & Earnings

This table compares Disaboom and TransMedics Group”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Disaboom	$890,000.00	0.47	-$170,000.00	N/A	N/A
TransMedics Group	$605.49 million	6.45	$190.29 million	$4.90	23.24

TransMedics Group has higher revenue and earnings than Disaboom.

Risk & Volatility

Disaboom has a beta of 1.68, suggesting that its share price is 68% more volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 1.98, suggesting that its share price is 98% more volatile than the S&P 500.

Institutional and Insider Ownership

99.7% of TransMedics Group shares are owned by institutional investors. 7.0% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Disaboom and TransMedics Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Disaboom	5.91%	N/A	N/A
TransMedics Group	31.43%	30.17%	11.39%

Analyst Recommendations

This is a breakdown of recent ratings for Disaboom and TransMedics Group, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Disaboom	0	0	0	0	0.00
TransMedics Group	0	5	7	0	2.58

TransMedics Group has a consensus target price of $152.33, indicating a potential upside of 33.74%. Given TransMedics Group’s stronger consensus rating and higher probable upside, analysts plainly believe TransMedics Group is more favorable than Disaboom.

Summary

TransMedics Group beats Disaboom on 12 of the 12 factors compared between the two stocks.

About Disaboom

Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.

About TransMedics Group

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.